A detailed history of Msh Capital Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Msh Capital Advisors LLC holds 23,505 shares of VTRS stock, worth $253,854. This represents 0.09% of its overall portfolio holdings.

Number of Shares
23,505
Previous 78,737 70.15%
Holding current value
$253,854
Previous $824 Million 64.5%
% of portfolio
0.09%
Previous 0.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$11.32 - $13.37 $625,226 - $738,451
-55,232 Reduced 70.15%
23,505 $293 Million
Q2 2024

Feb 13, 2025

BUY
$10.05 - $12.02 $8,994 - $10,757
895 Added 3.44%
26,939 $286 Million
Q1 2024

Feb 13, 2025

SELL
$11.27 - $13.53 $17,941 - $21,539
-1,592 Reduced 5.76%
26,044 $311 Million
Q4 2023

Feb 13, 2025

SELL
$8.77 - $10.85 $551,019 - $681,705
-62,830 Reduced 69.45%
27,636 $299 Million
Q3 2023

Feb 13, 2025

BUY
$9.59 - $11.35 $5,025 - $5,947
524 Added 0.58%
90,466 $892 Million
Q2 2023

Feb 13, 2025

BUY
$9.02 - $10.29 $17,534 - $20,003
1,944 Added 2.21%
89,942 $898 Million
Q1 2023

Feb 13, 2025

BUY
$9.2 - $12.26 $61,143 - $81,479
6,646 Added 8.17%
87,998 $847 Million
Q4 2022

Feb 13, 2025

BUY
$8.72 - $11.56 $18,939 - $25,108
2,172 Added 2.74%
81,352 $905 Million
Q3 2022

Feb 13, 2025

BUY
$8.48 - $11.13 $472,124 - $619,662
55,675 Added 236.86%
79,180 $675 Million
Q2 2022

Feb 13, 2025

BUY
$9.95 - $12.27 $20,188 - $24,895
2,029 Added 2.65%
78,737 $824 Million
Q1 2022

Feb 13, 2025

BUY
$9.81 - $15.4 $23,857 - $37,452
2,432 Added 3.27%
76,708 $835 Million
Q4 2021

Feb 13, 2025

BUY
$12.09 - $14.68 $897,996 - $1.09 Million
74,276 New
74,276 $1 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.